Ameristat
Pharmaceuticals, Inc. 
Milrinone
Injection
-
milrinone@aipharma.com
Indications and Usage for Milrinone
Milrinone lactate injection is indicated for the short-term intravenous
treatment of patients with acute decompensated heart failure. Patients
receiving Milrinone should be observed closely with appropriate
electrocardiographic equipment. The facility for immediate treatment of
potential cardiac events, which may include life threatening ventricular
arrhythmias, must be available. The majority of experience with
intravenous Milrinone has been in patients receiving digoxin and
diuretics. There is no experience in controlled trials with infusions of
Milrinone for periods exceeding 48 hours.
Learn more about Milrinone Injection at www.drugs.com/pro/milrinone.html